An overview of Monoclonal Antibodies and their The
Post# of 148190
For those new to Leronlimab and considering investing in CYDY...a must read...
researchgate.net/public.
"Hybridoma Technology"...The FDA has produced a "points to consider" paper, that advises producers on issues to consider while developing and testing MAbs for human use, as well as information that should be included in (IND)'s or (BLA)'s.
The therapeutic era of MAbs... is still in it's embryonic stages....and once again CCR5 is being centered out... as a gateway...to ameliorate damage.